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摘  要 
第一部分：局部应用前列腺素类药物对兔角膜上皮细胞屏障功能的影响 
目的：苯扎氯铵（BAK）是滴眼液中最常用的防腐剂之一，大量的临床研究






方法: 新西兰大白兔被随机的分成 4 组，每组 12 只，右眼为药物处理组，
分别给以贝美前列腺素（0.005% BAK），曲伏前列腺素（0.015% BAK），拉坦前





观察紧密连接标志物 ZO-1、occludin，粘着连接标志物 β-catenin 以及细胞增殖标























结构均没有明显改变。在前列腺素类药物实验组，用药 5d 后， TER 呈现 BAK
浓度依赖性的下降，0.02% BAK 处理组下降最为显著。药物处理 5d 后， ZO-1
和 occludin 在细胞膜上的分布破坏，而 β-catenin 的分布无明显变化，用药 30d
后，ZO-1 和 occludin 以及 β-catenin 的形态与结构均发生了明显的破坏。ki67 在
对照组和实验组无明显变化，TUNEL 试剂盒检测发现，局部应用前列腺素类药













































































Part1 Effect of Topical Application of Commercial Prostaglandin (PG) Analogs 
on Rabbit Corneal Epithelial Barrier Function 
Purpose：BAK is one of the most common preservative in eye preparations，
Prostaglandin (PG) analogs, including latanoprost, travoprost, and bimatoprost, are 
currently the most commonly used topical ocular hypotensive medications. The 
purpose of this study was to investigate the alterations of corneal barrier function in 
rabbits following exposure to commercial solution of latanoprost, travoprost and 
bimatoprost.  
Methods: Commercial latanoprost, travoprost, bimatoprost or 0.02% 
benzalkonium chloride (BAK) was applied once daily to one eye each of rabbits for 
30 days, the contralateral untreated eyes used as controls. Schirmer test, tear break-up 
time (BUT), rose Bengal and fluorescein staining were performed on days 5, 10, 20, 
and 30. Central corneal changes were analyzed by in vivo confocal microscopy and 
HE staining, and the corneal barrier function was evaluated by measurement of 
corneal transepithelial electrical resistance on day 5. Whole mount corneas were 
analyzed by using fluorescence confocal microscopy for the presence of tight-junction 
(ZO-1, occludin) and adherens-junction (β-catenin) proteins, actin cytoskeleton, 
proliferative marker Ki67 and cell apoptosis in the epithelium. 
Results: Topical application of commercial PG analogs resulted in significant 
corneal epithelial and stromal defects while no significant changes in aqueous tear 
production, BUT, rose bengal and fluorescein staining scores on day 5. Commercial 
PG analogs induced dislocation of ZO-1 and occludin from their normal locus, 
disorganization of cortical actin cytoskeleton at the superficial layer, and disruption of 
epithelial barrier function. The eyes treated with 0.02% BAK and latanoprost 
exhibited significantly reduced Schirmer scores, BUT, and increased fluorescein 














Conclusions: Topical application of commercial PG analogs can quickly impair 
the corneal epithelium and stroma without tear deficiency. Commercial PG analogs 
break down the barrier integrity of corneal epithelium, concomitant with the 
disruption of cell junction and actin cytoskeleton between superficial cells in the 
corneal epithelium in vivo. 
Key words: Prostaglandin (PG) analogs; corneal epithelial barrier function; 
ocular surface toxicity 
 
Abstract 
Part2 Topical Application of Benzalkonium Chloride Induced the Alteration of 
Gap Junction Intercellular Communication in Rabbit Corneal Endothelium 
Purpose：Gap junction intercellular communication (GJIC) plays a critical role 
in the maintenance of corneal endothelium homeostasis. We determined if 
benzalkonium chloride (BAK) alters GJIC activity in the rabbit corneal endothelium 
since it is commonly used as a drug preservative in ocular eyedrop preparations even 
though it can have cytotoxic effects. 
Methods: Thirty-six adult New Zealand albino rabbits were randomly divided 
into three groups. BAK at 0.01%, 0.05%, and 0.1% was applied twice daily to one eye 
of each of the rabbits in one of the three groups for seven days. The contralateral 
untreated eyes were used as controls. Corneal endothelial morphological features 
were observed by in vivo confocal microscopy (IVCM). Immunofluorescent staining 
resolved changes in gap junction integrity and localization. TUNEL assay was used to 
evaluate the apoptosis of rabbit corneal endothelium. Western blot analysis and 
RT-PCR evaluated changes in levels of connexin43 (Cx43) and tight junction zonula 
occludens-1 (ZO-1) gene and protein expression, respectively. Cx43 and ZO-1 
physical interaction was detected by immunoprecipitation (IP). Primary rabbit corneal 














containing BAK for 24 hours. The scrape-loading dye transfer technique (SLDT) was 
used to assess GJIC activity. 
Results: Topical administration of BAK (0.05%, 0.1%) dose dependently 
disrupted corneal endothelial cell morphology, altered Cx43 and ZO-1 distribution 
and reduced Cx43 expression. BAK also markedly induced increases in Cx43 
phosphorylation status concomitant with decreases in the Cx43-ZO-1 protein-protein 
interaction. These changes were associated with marked declines in GJIC activity. 
Conclusions: The dose dependent declines in rabbit corneal endothelial GJIC 
activity induced by BAK are associated with less Cx43-ZO-1 interaction possibly 
arising from increases in Cx43 phosphorylation and declines in its protein expression. 
These novel changes provide additional evidence that BAK containing eyedrop 
preparations should be used with caution to avoid declines in corneal transparency 
resulting from losses in GJIC activity and endothelial function. 
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